ABL1 | ABL proto-oncogene 1, non-receptor tyrosine kinase | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
ABL2 | ABL proto-oncogene 2, non-receptor tyrosine kinase | Cancer-related genes Enzymes Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
AKT1 | V-akt murine thymoma viral oncogene homolog 1 | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
AKT3 | V-akt murine thymoma viral oncogene homolog 3 | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
ANGPT1 | Angiopoietin 1 | Cancer-related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Mixed |
BAD | BCL2-associated agonist of cell death | Cancer-related genes Mitochondrial proteins Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
BCL2L1 | BCL2-like 1 | Cancer-related genes Mitochondrial proteins Predicted intracellular proteins Predicted membrane proteins RAS pathway related proteins Transporters
| | | | | Expressed in all |
BRAP | BRCA1 associated protein | Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
CALM1 | Calmodulin 1 (phosphorylase kinase, delta) | Cancer-related genes Disease related genes Plasma proteins Potential drug targets Predicted intracellular proteins RAS pathway related proteins Transporters
| | | | | Expressed in all |
CALM2 | Calmodulin 2 (phosphorylase kinase, delta) | Cancer-related genes Disease related genes Plasma proteins Potential drug targets Predicted intracellular proteins RAS pathway related proteins Transporters
| | | | | Expressed in all |
CALML5 | Calmodulin-like 5 | Plasma proteins Predicted intracellular proteins RAS pathway related proteins
| | | | | Group enriched |
CDC42 | Cell division cycle 42 | Plasma proteins Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
CHUK | Conserved helix-loop-helix ubiquitous kinase | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
EGFR | Epidermal growth factor receptor | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enhanced |
ELK1 | ELK1, member of ETS oncogene family | Predicted intracellular proteins RAS pathway related proteins Transcription factors
| | | | | Expressed in all |
EPHA2 | EPH receptor A2 | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Predicted membrane proteins RAS pathway related proteins
| | | | | Tissue enhanced |
ETS1 | V-ets avian erythroblastosis virus E26 oncogene homolog 1 | Plasma proteins Predicted intracellular proteins RAS pathway related proteins Transcription factors
| | | | | Expressed in all |
ETS2 | V-ets avian erythroblastosis virus E26 oncogene homolog 2 | Predicted intracellular proteins RAS pathway related proteins Transcription factors
| | | | | Expressed in all |
EXOC2 | Exocyst complex component 2 | Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
FGF1 | Fibroblast growth factor 1 (acidic) | Cancer-related genes FDA approved drug targets Predicted intracellular proteins RAS pathway related proteins
| | | | | Group enriched |
FGF13 | Fibroblast growth factor 13 | Predicted intracellular proteins RAS pathway related proteins
| | | | | Mixed |
FGF2 | Fibroblast growth factor 2 (basic) | Cancer-related genes Candidate cardiovascular disease genes FDA approved drug targets Predicted intracellular proteins RAS pathway related proteins
| | | | | Mixed |
FGF21 | Fibroblast growth factor 21 | Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enriched |
FGF5 | Fibroblast growth factor 5 | Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enhanced |
FGFR2 | Fibroblast growth factor receptor 2 | Cancer-related genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Mixed |
FGFR3 | Fibroblast growth factor receptor 3 | Cancer-related genes CD markers Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enriched |
FLT1 | Fms-related tyrosine kinase 1 | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enriched |
FLT4 | Fms-related tyrosine kinase 4 | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Mixed |
FOXO4 | Forkhead box O4 | Cancer-related genes Disease related genes Predicted intracellular proteins RAS pathway related proteins Transcription factors
| | | | | Tissue enriched |
GNB1 | Guanine nucleotide binding protein (G protein), beta polypeptide 1 | Cancer-related genes Plasma proteins Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
GNB2 | Guanine nucleotide binding protein (G protein), beta polypeptide 2 | Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
GNB4 | Guanine nucleotide binding protein (G protein), beta polypeptide 4 | Disease related genes Predicted intracellular proteins RAS pathway related proteins
| | | | | Mixed |
GNG12 | Guanine nucleotide binding protein (G protein), gamma 12 | Predicted intracellular proteins RAS pathway related proteins
| | | | | Mixed |
GNG13 | Guanine nucleotide binding protein (G protein), gamma 13 | Predicted intracellular proteins RAS pathway related proteins
| | | | | Tissue enhanced |
GRB2 | Growth factor receptor-bound protein 2 | Cancer-related genes Plasma proteins Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
GRIN2A | Glutamate receptor, ionotropic, N-methyl D-aspartate 2A | Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins RAS pathway related proteins
| | | | | Tissue enriched |
IKBKB | Inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta | Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
IKBKG | Inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma | Disease related genes Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
INS | Insulin | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enriched |
INSR | Insulin receptor | CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins RAS pathway related proteins
| | | | | Expressed in all |
KIT | V-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog | Cancer-related genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins RAS pathway related proteins
| | | | | Mixed |
KSR1 | Kinase suppressor of ras 1 | Enzymes Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
LAT | Linker for activation of T cells | Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enhanced |
MAP2K1 | Mitogen-activated protein kinase kinase 1 | Cancer-related genes Cytoskeleton related proteins Disease related genes Enzymes FDA approved drug targets Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
MAP2K2 | Mitogen-activated protein kinase kinase 2 | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
MAPK1 | Mitogen-activated protein kinase 1 | Cancer-related genes Cytoskeleton related proteins Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
MAPK3 | Mitogen-activated protein kinase 3 | Cancer-related genes Cytoskeleton related proteins Enzymes FDA approved drug targets Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
MAPK9 | Mitogen-activated protein kinase 9 | Enzymes Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
MET | MET proto-oncogene, receptor tyrosine kinase | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Expressed in all |
MLLT4 | Myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 4 | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |